Piper Sandler Reiterates Overweight on CME Group, Raises Price Target to $330
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsReiterationPrice TargetHot
Piper Sandler analyst Patrick Moley reiterates CME Group (NASDAQ:CME) with a Overweight and raises the price target from $295 to $330.
Piper Sandler analyst Patrick Moley reiterates CME Group (NASDAQ:CME) with a Overweight and raises the price target from $295 to $330.